NYSE : ACH
Accendra Health, Inc. — Key statistics
Materials · Metals & Mining · United States
Last price 0.233 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 17.92M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 19.55M |
| Enterprise Value | 1.83B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 76.90M |
| Shares Outstanding | 76.90M |
| Shares Change (YoY) | -0.47% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 9.79% |
| Owned by Institutions (%) | 79.52% |
| Float | 56.17M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| Forward PS | 0.01 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.69 |
| EV / EBITDA | 6.35 |
| EV / EBIT | 56.96 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.41 |
| Quick Ratio | 0.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.89 |
| Debt / FCF | n/a |
| Interest Coverage | 0.29 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 0.64% |
| Return on Invested Capital (ROIC) | 2.42% |
| Return on Capital Employed (ROCE) | 2.23% |
| Weighted Average Cost of Capital (WACC) | 4.94% |
| Revenue Per Employee | $407,268 |
| Profits Per Employee | -$46,483 |
| Employee Count | 6,500 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 20.49 |
Taxes
| Measure | Value |
|---|
| Income Tax | -4.89M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.57 |
| 52-Week Price Change | -95.13% |
| 50-Day Moving Average | 0.71 |
| 200-Day Moving Average | 2.24 |
| Relative Strength Index (RSI) | 25.93 |
| Average Volume (20 Days) | 2,219,674 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9.11M |
| Short Previous Month | 8.90M |
| Short % of Shares Out | 11.84% |
| Short % of Float | 16.21% |
| Short Ratio (days to cover) | 5.23 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.65B |
| Gross Profit | 1.19B |
| Operating Income | 32.16M |
| Pretax Income | -115.48M |
| Net Income | -302.14M |
| EBITDA | 288.23M |
| EBIT | 32.16M |
| Loss Per Share | -$3.95 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 7.65M |
| Total Debt | 1.82B |
| Net Cash | -1.81B |
| Net Cash Per Share | -$23.56 |
| Equity (Book Value) | -550.94M |
| Book Value Per Share | -7.16 |
| Working Capital | -394.77M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -180.42M |
| Capital Expenditures | -176.77M |
| Depreciation & Amortization | 256.08M |
| Net Borrowing | -135.00M |
| Free Cash Flow | -357.19M |
| FCF Per Share | -$4.64 |
Margins
| Measure | Value |
|---|
| Gross Margin | 44.83% |
| Operating Margin | 1.21% |
| Pretax Margin | -4.36% |
| Profit Margin | -11.41% |
| EBITDA Margin | 10.89% |
| EBIT Margin | 1.21% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.47% |
| Shareholder Yield | 0.47% |
| Earnings Yield | -1,552.19% |
| FCF Yield | -1,827.13% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $1.26 |
| Price Target Difference | 396.46% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | -0.95% |
| EPS Growth Forecast (3Y) | -36.34% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 1, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.37 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |